{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:38:19Z","timestamp":1790807899139,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1P20GM121312"],"award-info":[{"award-number":["1P20GM121312"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41386-020-00936-w","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:03:24Z","timestamp":1608228204000},"page":"1011-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-3606","authenticated-orcid":false,"given":"Martin P.","family":"Paulus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-2871","authenticated-orcid":false,"given":"Murray B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria B.","family":"Risbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Chaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8\u201319.","journal-title":"Arch Gen Psychiatry"},{"key":"936_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","volume":"21","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169\u201384.","journal-title":"Int J Methods Psychiatr Res"},{"key":"936_CR3","doi-asserted-by":"crossref","unstructured":"Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. The global burden of anxiety disorders in 2010. Psychol Med. 2014;44:1\u201312.","DOI":"10.1017\/S0033291713003243"},{"key":"936_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpr.2015.08.004","volume":"42","author":"AG Loerinc","year":"2015","unstructured":"Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. Response rates for CBT for anxiety disorders: Need for standardized criteria. Clin Psychol Rev. 2015;42:72\u201382.","journal-title":"Clin Psychol Rev"},{"key":"936_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.2017.6996","volume":"318","author":"MB Stein","year":"2017","unstructured":"Stein MB, Craske MG. Treating anxiety in 2017: optimizing care to improve outcomes. JAMA. 2017;318:235\u201336.","journal-title":"JAMA."},{"key":"936_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/10253890.2011.586753","volume":"14","author":"CJ Riebe","year":"2011","unstructured":"Riebe CJ, Wotjak CT. Endocannabinoids and stress. Stress. 2011;14:384\u201397.","journal-title":"Stress."},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","volume":"41","author":"M Morena","year":"2016","unstructured":"Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41:80\u2013102.","journal-title":"Neuropsychopharmacology."},{"key":"936_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015;16:705\u201318.","journal-title":"Nat Rev Neurosci"},{"key":"936_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00441-016-2544-1","volume":"368","author":"A Jafarpour","year":"2017","unstructured":"Jafarpour A, Dehghani F, Korf HW. Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? Cell Tissue Res. 2017;368:115\u201323.","journal-title":"Cell Tissue Res"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/jbcpp-2015-0058","volume":"27","author":"N Korem","year":"2016","unstructured":"Korem N, Zer-Aviv TM, Ganon-Elazar E, Abush H, Akirav I. Targeting the endocannabinoid system to treat anxiety-related disorders. J basic Clin Physiol Pharmacol. 2016;27:193\u2013202.","journal-title":"J basic Clin Physiol Pharmacol"},{"key":"936_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.53","volume":"4","author":"RJ Bluett","year":"2014","unstructured":"Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S. Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Transl Psychiatry. 2014;4:e408.","journal-title":"Transl Psychiatry"},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/mp.2012.90","volume":"18","author":"MN Hill","year":"2013","unstructured":"Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, et al. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry. 2013;18:1125\u201335.","journal-title":"Mol Psychiatry"},{"key":"936_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","volume":"34","author":"O Gunduz-Cinar","year":"2013","unstructured":"Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A. Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci. 2013;34:637\u201344.","journal-title":"Trends Pharmacol Sci"},{"key":"936_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pnpbp.2015.01.005","volume":"59","author":"SF Lisboa","year":"2015","unstructured":"Lisboa SF, Borges AA, Nejo P, Fassini A, Guimaraes FS, Resstel LB. Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence. Prog Neuropsychopharmacol Biol Psychiatry. 2015;59:76\u201383.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"936_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2003;9:76\u201381.","journal-title":"Nat Med"},{"key":"936_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","volume":"87","author":"LM Mayo","year":"2020","unstructured":"Mayo LM, Asratian A, Linde J, Morena M, Haataja R, Hammar V, et al. Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial. Biol Psychiatry. 2020;87:538\u201347.","journal-title":"Biol Psychiatry"},{"key":"936_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","volume":"98","author":"SG Kinsey","year":"2011","unstructured":"Kinsey SG, O\u2019Neal ST, Long JZ, Cravatt BF, Lichtman AH. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharm Biochem Behav. 2011;98:21\u20137.","journal-title":"Pharm Biochem Behav"},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.2174\/13816128113199990437","volume":"20","author":"CA Rabinak","year":"2014","unstructured":"Rabinak CA, Phan KL. Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment. Curr Pharm Des. 2014;20:2212\u20137.","journal-title":"Curr Pharm Des"},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/npp.2015.261","volume":"41","author":"JR Howlett","year":"2016","unstructured":"Howlett JR, Stein MB. Prevention of trauma and stressor-related disorders: a review. Neuropsychopharmacology 2016;41:357\u201369.","journal-title":"Neuropsychopharmacology"},{"key":"936_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","volume":"76","author":"S Patel","year":"2017","unstructured":"Patel S, Hill MN, Cheer JF, Wotjak CT, Holmes A. The endocannabinoid system as a target for novel anxiolytic drugs. Neurosci Biobehav Rev. 2017;76:56\u201366.","journal-title":"Neurosci Biobehav Rev"},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"155ps19","DOI":"10.1126\/scitranslmed.3004873","volume":"4","author":"TR Insel","year":"2012","unstructured":"Insel TR. Next-generation treatments for mental disorders. Sci Transl Med. 2012;4:155ps19.","journal-title":"Sci Transl Med"},{"key":"936_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-126","volume":"11","author":"BN Cuthbert","year":"2013","unstructured":"Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.","journal-title":"BMC Med"},{"key":"936_CR23","unstructured":"Health NIoM. Positive Valence Systems: Workshop Proceedings. 2011. http:\/\/www.nimh.nih.gov\/research-funding\/rdoc\/positive-valence-systems-workshop-proceedings.shtml. Accessed 10 Dec 2012."},{"key":"936_CR24","unstructured":"Health NIoM. Negative Valence Systems: Workshop Proceedings. 2011. http:\/\/www.nimh.nih.gov\/research-funding\/rdoc\/negative-valence-systems-workshop-proceedings.shtml. Accessed 10 Dec 2012."},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1037\/0097-7403.9.3.248","volume":"9","author":"ME Bouton","year":"1983","unstructured":"Bouton ME, King DA. Contextual control of the extinction of conditioned fear: tests for the associative value of the context. J Exp Psychol Anim Behav Process. 1983;9:248\u201365.","journal-title":"J Exp Psychol Anim Behav Process"},{"key":"936_CR26","first-page":"511","volume":"84","author":"E Griez","year":"1984","unstructured":"Griez E. Experimental models of anxiety. Problems and perspectives. Acta Psychiatr Belg. 1984;84:511\u201332.","journal-title":"Acta Psychiatr Belg"},{"key":"936_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1037\/0735-7044.100.6.814","volume":"100","author":"M Davis","year":"1986","unstructured":"Davis M. Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci. 1986;100:814\u201324.","journal-title":"Behav Neurosci"},{"key":"936_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","volume":"106","author":"RG Phillips","year":"1992","unstructured":"Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992;106:274\u201385.","journal-title":"Behav Neurosci"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0896-6273(00)80475-4","volume":"20","author":"KS Labar","year":"1998","unstructured":"Labar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998;20:937\u201345.","journal-title":"Neuron"},{"key":"936_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0959-4388(00)00078-7","volume":"10","author":"C Buchel","year":"2000","unstructured":"Buchel C, Dolan RJ. Classical fear conditioning in functional neuroimaging. Curr Opin Neurobiol. 2000;10:219\u201323.","journal-title":"Curr Opin Neurobiol"},{"key":"936_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopsycho.2006.01.006","volume":"73","author":"MR Delgado","year":"2006","unstructured":"Delgado MR, Olsson A, Phelps EA. Extending animal models of fear conditioning to humans. Biol Psychol. 2006;73:39\u201348.","journal-title":"Biol Psychol"},{"key":"936_CR32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","volume":"164","author":"A Etkin","year":"2007","unstructured":"Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476\u201388.","journal-title":"Am J Psychiatry"},{"key":"936_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/nimg.2002.1179","volume":"17","author":"AR Hariri","year":"2002","unstructured":"Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002;17:317\u201323.","journal-title":"Neuroimage"},{"key":"936_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1192\/bjp.bp.114.149880","volume":"206","author":"GA Fonzo","year":"2015","unstructured":"Fonzo GA, Ramsawh HJ, Flagan TM, Sullivan SG, Letamendi A, Simmons AN, et al. Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders. Br J Psychiatry. 2015;206:206\u201315.","journal-title":"Br J Psychiatry"},{"key":"936_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/archpsyc.62.3.282","volume":"62","author":"MP Paulus","year":"2005","unstructured":"Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry. 2005;62:282\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"936_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biopsych.2006.03.042","volume":"60","author":"MP Paulus","year":"2006","unstructured":"Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60:383\u20137.","journal-title":"Biol Psychiatry"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrn894","volume":"3","author":"AD Craig","year":"2002","unstructured":"Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3:655\u201366.","journal-title":"Nat Rev Neurosci"},{"key":"936_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"AD Craig","year":"2009","unstructured":"Craig AD. How do you feel\u2014now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59\u201370.","journal-title":"Nat Rev Neurosci"},{"key":"936_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0301-0511(95)05144-9","volume":"42","author":"D Vaitl","year":"1996","unstructured":"Vaitl D. Interoception. Biol Psychol. 1996;42:1\u201327.","journal-title":"Biol Psychol"},{"key":"936_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0165-0173(96)00011-2","volume":"22","author":"JR Augustine","year":"1996","unstructured":"Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev. 1996;22:229\u201344.","journal-title":"Brain Res Brain Res Rev"},{"key":"936_CR41","first-page":"272","volume-title":"Handbook of Emotions","author":"AD Craig","year":"2007","unstructured":"Craig AD. Interoception and Emotion: a Neuroanatomical Perspective. In: Lewis M, Haviland-Jones JM, Feldman Barrett L, eds. Handbook of Emotions. New York, NY: Guilford Press; 2007. p. 272\u201390."},{"key":"936_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pbb.2019.03.006","volume":"180","author":"AK Andrade","year":"2019","unstructured":"Andrade AK, Renda B, Murray JE. Cannabinoids, interoception, and anxiety. Pharm Biochem Behav. 2019;180:60\u201373.","journal-title":"Pharm Biochem Behav"},{"key":"936_CR43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1021\/acsmedchemlett.5b00353","volume":"6","author":"JM Keith","year":"2015","unstructured":"Keith JM, Jones WM, Tichenor M, Liu J, Seierstad M, Palmer JA, et al. Preclinical characterization of the FAAH inhibitor JNJ-42165279. ACS Med Chem Lett. 2015;6:1204\u20138.","journal-title":"ACS Med Chem Lett"},{"key":"936_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnsys.2013.00089","volume":"7","author":"JL Stewart","year":"2013","unstructured":"Stewart JL, Parnass JM, May AC, Davenport PW, Paulus MP. Altered frontocingulate activation during aversive interoceptive processing in young adults transitioning to problem stimulant use. Front Syst Neurosci. 2013;7:89.","journal-title":"Front Syst Neurosci"},{"key":"936_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1017\/S0033291710001248","volume":"41","author":"C Sehlmeyer","year":"2011","unstructured":"Sehlmeyer C, Dannlowski U, Schoning S, Kugel H, Pyka M, Pfleiderer B, et al. Neural correlates of trait anxiety in fear extinction. Psychol Med. 2011;41:789\u201398.","journal-title":"Psychol Med"},{"key":"936_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.1071829","volume":"297","author":"AR Hariri","year":"2002","unstructured":"Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400\u201303.","journal-title":"Science."},{"key":"936_CR47","doi-asserted-by":"publisher","first-page":"e29394","DOI":"10.1371\/journal.pone.0029394","volume":"7","author":"MP Paulus","year":"2012","unstructured":"Paulus MP, Flagan T, Simmons AN, Gillis K, Kotturi S, Thom N, et al. Subjecting elite athletes to inspiratory breathing load reveals behavioral and neural signatures of optimal performers in extreme environments. PLoS One. 2012;7:e29394.","journal-title":"PLoS One"},{"key":"936_CR48","doi-asserted-by":"publisher","first-page":"e5865","DOI":"10.1371\/journal.pone.0005865","volume":"4","author":"C Sehlmeyer","year":"2009","unstructured":"Sehlmeyer C, Schoning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, et al. Human fear conditioning and extinction in neuroimaging: a systematic review. PloS one. 2009;4:e5865.","journal-title":"PloS one"},{"key":"936_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162\u201373.","journal-title":"Comput Biomed Res"},{"key":"936_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1006\/nimg.2000.0592","volume":"11","author":"JV Haxby","year":"2000","unstructured":"Haxby JV, Petit L, Ungerleider LG, Courtney SM. Distinguishing the functional roles of multiple regions in distributed neural systems for visual working memory [see comments]. Neuroimage 2000;11:380\u201391.","journal-title":"Neuroimage"},{"key":"936_CR51","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/mrm.1910360615","volume":"36","author":"WF Eddy","year":"1996","unstructured":"Eddy WF, Fitzgerald M, Noll DC. Improved image registration by using Fourier interpolation. Magn Reson Med. 1996;36:923\u201331.","journal-title":"Magn Reson Med"},{"key":"936_CR52","doi-asserted-by":"crossref","unstructured":"Ball TM, Knapp SE, Paulus MP, Stein MB. Brain activation during fear extinction predicts exposure success. Depress Anxiety. 2017;34:257\u201366.","DOI":"10.1002\/da.22583"},{"key":"936_CR53","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1523\/JNEUROSCI.16-13-04207.1996","volume":"16","author":"GM Boynton","year":"1996","unstructured":"Boynton GM, Engel SA, Glover GH, Heeger DJ. Linear systems analysis of functional magnetic resonance imaging in human V1. J Neurosci. 1996;16:4207\u201321.","journal-title":"J Neurosci"},{"key":"936_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/nimg.1995.1018","volume":"2","author":"KJ Friston","year":"1995","unstructured":"Friston KJ, Frith CD, Turner R, Frackowiak RS. Characterizing evoked hemodynamics with fMRI. Neuroimage. 1995;2:157\u201365.","journal-title":"Neuroimage."},{"key":"936_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/nimg.1997.0278","volume":"6","author":"MS Cohen","year":"1997","unstructured":"Cohen MS. Parametric analysis of fMRI data using linear systems methods. Neuroimage. 1997;6:93\u2013103.","journal-title":"Neuroimage."},{"key":"936_CR56","unstructured":"Pinheiro JB, D; DebRoy, S; Sarkar, D. Linear and Nonlinear Mixed Effects Models. http:\/\/CRAN.R-project.org\/package=nlme (2016)."},{"key":"936_CR57","unstructured":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria; 2010."},{"key":"936_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.npp.1300601","volume":"30","author":"MN Hill","year":"2005","unstructured":"Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 2005;30:508\u201315.","journal-title":"Neuropsychopharmacology."},{"key":"936_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","volume":"204","author":"RJ McLaughlin","year":"2012","unstructured":"McLaughlin RJ, Gobbi G. Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience. 2012;204:134\u201344.","journal-title":"Neuroscience."},{"key":"936_CR60","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.euroneuro.2012.01.004","volume":"22","author":"RJ McLaughlin","year":"2012","unstructured":"McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, et al. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. Eur Neuropsychopharmacol. 2012;22:664\u201371.","journal-title":"Eur Neuropsychopharmacol"},{"key":"936_CR61","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/bies.201500046","volume":"37","author":"A Busquets-Garcia","year":"2015","unstructured":"Busquets-Garcia A, Desprez T, Metna-Laurent M, Bellocchio L, Marsicano G, Soria-Gomez E. Dissecting the cannabinergic control of behavior: the where matters. Bioessays. 2015;37:1215\u201325.","journal-title":"Bioessays."},{"key":"936_CR62","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1523\/JNEUROSCI.2251-18.2018","volume":"39","author":"M Morena","year":"2019","unstructured":"Morena M, Aukema RJ, Leitl KD, Rashid AJ, Vecchiarelli HA, Josselyn SA, et al. Upregulation of anandamide hydrolysis in the basolateral complex of amygdala reduces fear memory expression and indices of stress and anxiety. J Neurosci. 2019;39:1275\u201392.","journal-title":"J Neurosci"},{"key":"936_CR63","doi-asserted-by":"publisher","first-page":"107965","DOI":"10.1016\/j.neuropharm.2020.107965","volume":"166","author":"A Vimalanathan","year":"2020","unstructured":"Vimalanathan A, Gidyk DC, Diwan M, Gouveia FV, Lipsman N, Giacobbe P, et al. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. Neuropharmacology. 2020;166:107965.","journal-title":"Neuropharmacology."},{"key":"936_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2016.04.014","volume":"308","author":"MA Burman","year":"2016","unstructured":"Burman MA, Szolusha K, Bind R, Kerney K, Boger DL, Bilsky EJ. FAAH inhibitor OL-135 disrupts contextual, but not auditory, fear conditioning in rats. Behav Brain Res. 2016;308:1\u20135.","journal-title":"Behav Brain Res"},{"key":"936_CR65","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41386-018-0135-4","volume":"43","author":"A Segev","year":"2018","unstructured":"Segev A, Korem N, Mizrachi Zer-Aviv T, Abush H, Lange R, Sauber G, et al. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity. Neuropsychopharmacology. 2018;43:2017\u201327.","journal-title":"Neuropsychopharmacology."},{"key":"936_CR66","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/mp.2012.72","volume":"18","author":"O Gunduz-Cinar","year":"2013","unstructured":"Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry. 2013;18:813\u201323.","journal-title":"Mol Psychiatry"},{"key":"936_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7395","volume":"6","author":"I Dincheva","year":"2015","unstructured":"Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC, et al. FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun. 2015;6:6395.","journal-title":"Nat Commun"},{"key":"936_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-5380-2-7","volume":"2","author":"K Lebron-Milad","year":"2012","unstructured":"Lebron-Milad K, Abbs B, Milad MR, Linnman C, Rougemount-Bucking A, Zeidan MA, et al. Sex differences in the neurobiology of fear conditioning and extinction: a preliminary fMRI study of shared sex differences with stress-arousal circuitry. Biol Mood Anxiety Disord. 2012;2:7.","journal-title":"Biol Mood Anxiety Disord"},{"key":"936_CR69","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.biopsych.2005.10.015","volume":"59","author":"CJ Harmer","year":"2006","unstructured":"Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 2006;59:816\u201320.","journal-title":"Biol Psychiatry"},{"key":"936_CR70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/mp.2011.16","volume":"17","author":"M Di Simplicio","year":"2012","unstructured":"Di Simplicio M, Norbury R, Harmer CJ. Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression. Mol Psychiatry. 2012;17:503\u201310.","journal-title":"Mol Psychiatry"},{"key":"936_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature08637","volume":"463","author":"D Schiller","year":"2010","unstructured":"Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010;463:49\u201353.","journal-title":"Nature"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00936-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:09:18Z","timestamp":1650247758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-00936-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-00936-w","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}